SNDK · Investment summary · as of 3 August 2026
Priced for an operating path the record does not support
Business type: Transition · cyclical or commodity-sensitive
The operating path required by today's price is not achievable on the evidence.
At $1,288.33, SNDK requires a 69% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 0%.
The market's disagreement with history is not units - Q3 exabytes were flat - it is the permanence of NAND pricing, i.e. terminal margin structure.
The value rests on an exit multiple of 10.0x, a terminal operating margin of 12% and a 15.5% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: NAND supply response converts shortage to glut post-FY2027 (Kioxia/SNDK BiCS adds + Samsung/SK Hynix/YMTC expansion - the FY2023 mechanism: revenue -38%, GM 7.1%).
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The market's disagreement with history is not units - Q3 exabytes were flat - it is the permanence of NAND pricing, i.e. terminal margin structure. |
| What do we forecast? | Revenue growth of 0% demonstrated; a terminal operating margin of 12%; an exit multiple of 10.0x. |
| What does Street forecast? | Consensus: current-year earnings per share $66.10. |
| Where do we differ? | On terminal margin, the difference between what the price requires and what the business has demonstrated is -34.2 percentage points. |
| What is it worth? | Not determined — Context, not adopted: 6.0x FY27E EPS is where memory names have historically peaked (peak earnings x trough multiple); scenario-weighted 12m E[R] -15.7%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| RPO note, quarterly | Contracted backlog eroding or cancelling | RPO at or above $35bn in the FY2026 10-K or any FY2027 10-Q without commensurate revenue recognition | RPO below $35bn in the FY2026 10-K or any FY2027 10-Q without commensurate revenue recognition |
| 10-Q MD&A ASP disclosure | Pricing regime cracking without volume offset | Neither leg of the condition opposite is met at this date | Blended ASP/GB declines sequentially in any FY2027 quarter while exabyte growth < 10% |
| 10-Q income statement | The contracted-price floor failing to hold margin structure | Gross margin at or above 50% for two consecutive quarters in FY2027 | Gross margin below 50% for two consecutive quarters in FY2027 |
| consensus estimates, monthly | The post-peak repricing beginning | Street FY2027 revenue consensus revised at or above $38bn (current consensus low) | Street FY2027 revenue consensus revised below $38bn (current consensus low) |
NAND supply response converts shortage to glut post-FY2027 (Kioxia/SNDK BiCS adds + Samsung/SK Hynix/YMTC expansion - the FY2023 mechanism: revenue -38%, GM 7.1%). The uncontracted ~85-87% of priced-in revenue reverts; the contracted tranche and FY27 cash accumulation truncate the loss (Principle 5: the RPO raises the bear FLOOR).
Estimated probability 45%, against the 13% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.
Falsifiable and fundamental — not one of them is a price condition.
The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | Through-cycle ROIC ~0 and TTM ROIC is a cycle-peak artifact - reported, not scored; the cycle call is Tier-2 judgement and deliberately unscored under CYCLICAL/TRANSITION. |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | NAND supply response converts shortage to glut post-FY2027 (Kioxia/SNDK BiCS adds + Samsung/SK Hynix/YMTC expansion - the FY2023 mechanism: revenue -38%, GM 7.1%). |
| Momentum | Met | $42.50 (4 August 2025) -> $1,743.66 (2 July 2026); top of any cross-sectional universe by construction. Spot -26.1% off the high - the tape has already cracked once; ATR20 15.1%/day. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Met | Is the house-versus-Street disagreement identified and quantified? |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -34.2 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: NAND supply response converts shortage to glut post-FY2027 (Kioxia/SNDK BiCS adds + Samsung/SK Hynix/YMTC expansion - the FY2023 mechanism: revenue -38%, GM 7.1%). The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $966.25, which forces an immediate review.